The RSU Institute of Microbiology and Virology has focused on studying autoimmune dimensions of fibromyalgia (FM) and is exploring the unique interactions between various biomarkers in fibromyalgia patients. The study aims to improve diagnostic and prognostic accuracy by promoting effective and personalized treatment approaches for fibromyalgia.